# An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety of Denosumab Administration in Postmenopausal Women With Low Bone Mineral Density

> **NCT00325468** · PHASE3 · COMPLETED · sponsor: **Amgen** · enrollment: 200 (actual)

## Conditions studied

- Low Bone Mineral Density

## Interventions

- **DRUG:** AMG 162

## Key facts

- **NCT ID:** NCT00325468
- **Lead sponsor:** Amgen
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05-01
- **Primary completion:** 2011-03-28
- **Final completion:** 2012-08-02
- **Target enrollment:** 200 (ACTUAL)
- **Last updated:** 2017-08-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00325468

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00325468, "An Open-label, Single-arm Extension Study to Evaluate the Long-term Safety of Denosumab Administration in Postmenopausal Women With Low Bone Mineral Density". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT00325468. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*